Cargando…
Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting
Cefiderocol is a new cephalosporin with a catechol in its chemical structure faciliting its access to the interior of bacteria through iron channels. In addition, it is broadly stable to beta-lactamases. The pharmacokinetic profile is a beta-lactam one: no oral absorption, and with a wide distributi...
Autores principales: | Perea, José Ramón Azanza, de Rada, Belén Sádaba Díaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632061/ https://www.ncbi.nlm.nih.gov/pubmed/36193982 http://dx.doi.org/10.37201/req/s02.04.2022 |
Ejemplares similares
-
Clinical experience of cefiderocol
por: Fariñas, María Carmen
Publicado: (2022) -
The role of cefiderocol in clinical practice
por: Maseda, Emilio, et al.
Publicado: (2022) -
Mechanism of action of cefiderocol
por: Soriano, Alex, et al.
Publicado: (2022) -
Antibacterial spectrum of cefiderocol
por: Cordero, Desirée Gijón, et al.
Publicado: (2022) -
Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives
por: Garcia-Bustos, Víctor, et al.
Publicado: (2022)